Company Filing History:
Years Active: 1992-2025
Title: Innovations by Inventor Elias Aizenman
Introduction
Elias Aizenman is a prominent inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of neuroprotection, holding a total of 5 patents. His work focuses on developing novel compounds and peptides that can aid in treating various neurological disorders.
Latest Patents
Aizenman's latest patents include groundbreaking research on neuroprotective mechanisms. One of his notable patents is titled "Neuroprotective disruption of Kv2.1/syntaxin interaction by small molecules." This patent discloses small molecule compounds capable of disrupting the binding between Kv2.1 and syntaxin, which can be useful for treating a variety of neurological disorders, diseases, and injuries. Another significant patent is "Neuroprotective peptides and methods of their use." This patent describes neuroprotective peptides derived from the voltage-gated potassium channel Kv2.2. These peptides promote the dispersal of the cognate channel Kv2.1 in neurons, blocking pro-apoptotic potassium efflux and preserving cell viability after apoptotic injury. The methods outlined in this patent also include the fusion of neuroprotective peptides to a cell-penetrating peptide to enhance cellular uptake.
Career Highlights
Elias Aizenman is affiliated with the University of Pittsburgh, where he conducts his research and development work. His innovative approaches have positioned him as a key figure in the field of neuroprotection.
Collaborations
Aizenman has collaborated with notable colleagues, including Paul A. Rosenberg and Paul M. Gallop. Their combined expertise has contributed to the advancement of research in neuroprotective strategies.
Conclusion
Elias Aizenman's work exemplifies the impact of innovative research in the field of neuroscience. His patents reflect a commitment to developing solutions for neurological disorders, showcasing the importance of collaboration and innovation in scientific advancement.